Retailer collapses with $3.6m of debt – news.com.au

A Victorian fashion company has become the latest casualty in Australias struggling retail sector after collapsing into liquidation. Last Tuesday, Melbourne-based retailer Nobody Denim went into voluntary liquidation. Nobody Denim supplied its apparel to The Iconic, David Jones and more than 100 other operators across Australia and New Zealand. The business reportedly made $5.6 million…

J&J MedTech is restructuring its DePuy Synthes orthopedics unit – Mass Device

Johnson & Johnson MedTech is restructuring its DePuy Synthes orthopedic business, executives said today on a quarterly earnings call with investors. J&J (NYSE: JNJ) + CFO Joe Wolk said the two-year restructuring program will take the orthopedics unit out of less profitable markets and product lines to improve the segments profitability after it reported 2.6%…

Johnson & Johnson begins restructuring at medical device unit after … – The Globe and Mail

Open this photo in gallery: The company logo for Johnson & Johnson at the New York Stock Exchange, on Sept. 17, 2019.BRENDAN MCDERMID/Reuters Johnson & Johnson JNJ-N on Tuesday said it has embarked on a two-year restructuring program for its orthopedic business after third-quarter medical devices sales fell short of Wall Street expectations, reflecting the…

J&J to restructure orthopedics business – MedTech Dive

Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. By the numbers Q3 sales: $21.35 billion 6.8% increase year-over-year Net income: $4.31 billion Flat year-over-year Medtech sales: $7.46 billion 10% increase year-over-year Orthopaedics restructuring Johnson & Johnson announced it will restructure its orthopedics business, with plans…

J&J begins restructuring at medical device unit after sales miss – Reuters

Companies Johnson & Johnson Follow Kenvue Inc Follow Novo Nordisk A/S Follow Oct 17 (Reuters) – Johnson & Johnson (JNJ.N) on Tuesday said it has embarked on a two-year restructuring program for its orthopedic business after third-quarter medical devices sales fell short of Wall Street expectations, reflecting the company’s narrowed focus since spinning off its…